Discovery of 3-aryl substituted benzoxaboroles as broad-spectrum inhibitors of serine- and metallo-β-lactamases
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 41, 127956
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Sichuan Provincial Science and Technology Support Program
This publication has 27 references indexed in Scilit:
- Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases2015
- Molecular mechanisms of antibiotic resistanceNature Reviews Microbiology, 2014
- β-Lactam/β-Lactamase Inhibitor CombinationsAnnals of Pharmacotherapy, 2014
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales dataThe Lancet Infectious Diseases, 2014
- Synthesis of 3-Indolyl-substituted Benzoboroxole via Friedel-Crafts Reaction in WaterChinese Journal of Organic Chemistry, 2014
- Assay Platform for Clinically Relevant Metallo-β-lactamasesJournal of Medicinal Chemistry, 2013
- Tackling antibiotic resistanceNature Reviews Microbiology, 2011
- Current Challenges in Antimicrobial ChemotherapyDrugs, 2010
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Antibacterial resistance worldwide: causes, challenges and responsesNature Medicine, 2004